In today’s briefing:
- Mankind Pharma IPO Trading – Strong Insti Demand Makes up for Retail Lag
- Global Health (Medanta) Lockup – Good Name but Seems Fairly Valued
Mankind Pharma IPO Trading – Strong Insti Demand Makes up for Retail Lag
- Mankind Pharma raised around US$527m in its upcoming India IPO.
- MP is a pharmaceutical company engaged in developing, manufacturing and marketing a range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
- We have looked at various aspects of the deal in our previous note, in this note, we talk about the demand and trading dynamics.
Global Health (Medanta) Lockup – Good Name but Seems Fairly Valued
- Global Health (Medanta) (MEDANTA IN) raised around US$268m in its India IPO. The stock was listed on 16th Nov 2022, its six-month lockup will expire on 11th May 2023.
- Global Health (GH) is a hospital network that operates under the Medanta brand. The firm currently has five hospitals in operation and one more planned for development.
- In this note, we will talk about the lock-up dynamics and updates since our last note.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
